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Abstract
Background and aims Although visceral hypersensitivity is
a major pathophysiological feature of irritable bowel
syndrome (IBS), its molecular mechanisms are still poorly
understood. c-fos is a well-established marker of cell
activation. Accumulating evidence demonstrates that nor-
epinephrine (NE) system is dysregulated in IBS; however,
very little is known on its mechanism. It is our hypothesis
that elevated expression of c-fos in central nervous system
(CNS) correlates with visceral hypersensitivity in rat model
of IBS. Furthermore, we explored the changes of NE system
in IBS patients.
Methods The rat model of IBS was induced by heterotypic
chronic and acute stress. Tissues obtained from rat model
were analyzed for c-fos levels in CNS (frontal lobe,
hippocampus, cornu dorsale) and colon by immunohisto-
chemistry. Real-time reverse transcription polymerase chain
reaction was used to detect tyrosine hydroxylase (TH) in
the colonic tissues obtained from IBS patients.
Results The rat model of IBS was associated with increased
expression of c-fos in different parts of CNS (P=0.001, P=
0.002, and P=0.002, respectively), but normal in colon (P=
0.207). The clinical parameters (colonic motility and
sensation) of rat model were significantly correlated with
elevated c-fos in CNS (P<0.05). Enterochromaffin cells
and serotonin in colon were related to the elevated c-fos in
CNS (P<0.05). The TH messenger ribonucleic acid
(mRNA level of IBS-D patients was almost four times as
much as that of controls.
Conclusions Elevated expression of c-fos in CNS might be
one of key mechanisms in etiology of IBS. Therefore,
regulation of CNS activation could be a major targeting
effect when treating IBS patients.
Keywords Irritable bowel syndrome.c-fos.
Norepinephrine.Tyrosine hydroxylase
Introduction
Irritable bowel syndrome (IBS) is a highly prevalent func-
tional disorder of the gastrointestinal (GI) tract characterized
by the presence of abdominal pain or discomfort, an alteration
in bowel habit, and the absence of reproducible biomarkers
[1]. Several pathophysiological mechanisms have been
reported to play a role in the pathogenesis of IBS, among
which are visceral hypersensitivity [2], central nervous
system (CNS) dysregulation [3], alterations of gastrointesti-
nal (GI) motility [4], and abnormalities in neurotransmitter
systems such as serotonin (5-HT) [5]. However, the definite
mechanism is still poorly understood. There is general
agreement that increased sensitivity to stimuli arising from
the gut wall (i.e., visceral hypersensitivity) contributes to
abdominal pain/discomfort in IBS patients [6].
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DOI 10.1007/s00384-011-1153-4The causes underlying the visceral hypersensitivity in
IBS are only partially understood. Recent studies on the
pathophysiology of visceral hypersensitivity have demon-
strated abnormal neuroendocrine reactions within the gut
wall. There is evidence for altered signaling at the mucosal
level as indicated by studies using mucosal biopsy super-
natants from IBS patients. Soluble factors released from
colonic mucosal specimens of IBS patients activate visceral
afferent neurons and induce visceral hypersensitivity in rats
[7] and mice [8]. After measuring serotonin, histamine and
tryptase concentrations in colonic biopsy specimens from
patients with IBS and controls, Buhner et al. [9] concluded
that altered signaling in mucosa and the enteric nervous
system might be involved in IBS pathogenesis.
Norepinephrine (NE) is one of the most important
neurotransmitters within the GI tract [10, 11]. The
generation of NE is rate limited by tyrosine hydroxylase
(TH) [12]. TH is the first rate-limiting enzyme in the
process of NE synthesis, whose activity affects synthetic
process of NE. Lately, most attention has been focused on
visceral hypersensitivity related to dysfunction of the NE
system. Some authors raised the hypothesis that NE
signaling might be involved in the visceral hypersensitivity
of IBS. Several investigators measuring blood, urine, or
saliva noted higher levels of NE in patients with IBS
relative to healthy controls (HCs) [13–19]. Kim et al. [20]
found association of distinct alpha (2) adrenoceptor poly-
morphisms with constipation and somatic symptoms in
functional GI disorders, but did not find association of
norepiphrine transporter (NET) with IBS. Until now, most
studies put emphasis on NE signaling in body fluid
(plasma, urine, saliva, cerebrospinal fluid, and so on) of
IBS, and the results were liable to be influenced. But NE
signaling in tissue (such as colonic mucosa) of IBS has
been scarcely studied yet. Since our prior study has found
that NE system (NET and α2A-AR) in colon of IBS model
altered significantly in comparison with controls [21], we
further investigated the significance of TH in IBS in the
study.
c-fos expression is a well-established marker of neuronal
activation, and immunohistochemical detection of c-fos
allows a mapping of activated nervous tissues on a single-
cell level [22]. Some studies have shown that noxious
distension of hollow viscera (i.e., colorectum, esophagus,
and stomach) induces a specific pattern of c-fos expression
in the rat spinal cord and some of brain nuclei [23]. Little is
known about the activity of CNS and GI tract in patients
with IBS. Therefore, in the present study, we used the
brain–gut interaction animal model of IBS which we
established in our laboratory to identify activity of CNS
and colon, as assessed by induction of c-fos expression.
The previous studies largely emphasized the significance
of serotonin signaling in colon from patients with IBS,
whereas very limited study about NE signaling at colonic
mucosal level was carried out. In this study, we first
investigated NE signaling in human colonic mucosa of IBS
patients with two aims. First, the brain–gut interaction
animal model [the combined chronic and acute stress
(CAS) rats] of our lab had been validated and can simulate
the disturbed sensory–motor function of gut, visceral
hypersensitivity, mental behaviors of patients with IBS-D
[21]. Hence, we used this model to test the hypothesis that
altered c-fos, a well-established marker of cell activation, in
CNS might be the probable molecular mechanism of
visceral hypersensitivity in IBS. Second, this was also
carried out to evaluate changes of TH in colonic mucosa of
patients with IBS and to compare the expression of TH and
c-fos between IBS and controls and the probable molecular
mechanism.
Materials and methods
Rat model of IBS
Wistar male rats weighing 200–220 g each were used for
the experimental procedures. The rats were allowed 1 week
to acclimate to the surroundings before beginning the
experiment. The animals were housed in individual plastic
cages (25×25×35 cm). Standard rat food and tap water
were available ad libitum for the duration of the experi-
ments unless otherwise noted. The temperature was main-
tained at 22±2°C. A 12/12 h light/dark cycle was
maintained unless otherwise noted. Then the rats were
randomly divided into three groups. Group 1, the control
animals, were left undisturbed in the home cages with the
exception of general handling. In Group 2, the chronic
stress (CS group, the chronic mild stress procedure was
designed to maximize the unpredictable nature of the
stressors. The CS group was exposed to the following
seven stressors at random order: overnight illumination for
12 h, 45°C hot environment for 5 min, water deprivation
for 24 h, 4°C cold environment for 3 min, tail clamp for
1 min, level vibration (120/min) for 40 min, and food
deprivation for 24 h. The stressors were presented in the
order shown during the 1st week and were repeated each of
the weeks for a total of 3 weeks. Group 3, the CAS group
[21], was treated as CS group first and, after 7 days of rest,
1 h of acute restraint stress was given to these group of rats.
The frontal lobe, hippocampus, cornu dorsale, and distal
colon were taken from rat models and stored at −80°C.
The rats’ clinical parameters were as follows: The body
weight gain can be an indicator of the rats’ general state.
The number of fecal pellets expelled in 1 h was used as an
indirect measure of colonic motility [24]. Colonic sensation
was represented by abdominal muscle contractions under
1036 Int J Colorectal Dis (2011) 26:1035–1044different levels (0, 0.4, 0.8, and 1.2 ml) of colorectal
balloon distension (CRD).
Analysis of c-fos, EC cells, and serotonin (5-HT)
by histology and immunohistochemistry
Rats were anesthetized by sodium pentobarbital, and all
efforts were made to minimize suffering. The frontal lobe,
hippocampus, cornu dorsale, and distal colon specimens were
collected.Allthe tissues werefixed inbuffered 10% formalin.
Paraffin-embedded specimens were cut with a microtome at
3–4 μm, mounted on to gelatin-coated slides, and processed
for either hematoxylin–eosin (HE) stain histology or immu-
nohistochemistry. Paraffin sections were deparaffinized be-
fore processing. The antigen was retrieved by microwaving at
750 W for 2 min in 0.01 mol/l tri-sodium citrate buffer, pH
6.0. 3% hydrogen peroxide for 10 min in order to block
endogenous peroxidase activity, and sections were incubated
with rabbit monoclonal antibodies directed against c-fos
(dilutedat1:800;Santa Cruz,USA), chromograninA (diluted
at 1:50; Neuromaker, USA), or serotonin (diluted at 1:150;
Neuromaker), respectively, overnight at 4°C. Following
thorough washing with paraformaldehyde in phosphate-
buffered saline (PBS), slides were reincubated for 30 min at
37°C with secondary goat anti-mouse-rabbit antibodies
(1:200; Gene Tech, USA) followed byhorseradish peroxidase
conjugate. 3,3′-Diamino-benzidine-tetrahydrochloride (DAB)
solution prepared by dissolving one DAB-buffer tablet in
10 ml distilled water for 3 min. All incubation steps were
performed at room temperature. Between steps, the sections
were washed three times for 2 min with PBS (0.01 mol/
l phosphate buffer, pH7.4) and withdistilled water after DAB
staining. All dilutions were in PBS, containing 0.1% BSA
(Sigma) for dilution of the primary antibody. Controls for the
specificity of immunohistochemistry included a foregone
positive section of human colon carcinoma is used as positive
control, the replacement of the primary antibody with PBS as
negativecontrol,andthenormalcolonictissueasowncontrol.
Quantification of c-fos was performed with an Olympus
CH-2 microscope using a computer-assisted analysis system.
Briefly, this method adapts a morphometric point-counting
technique to quantify the area covered by c-fos in the rats’
tissues. The results were expressed as opacity density (OD).
Study participants and tissue samples
Patients [n=29; 19 with diarrhea-predominant IBS (IBS-D)
and 10 with constipation-predominant IBS (IBS-C); Table 1]
and healthy volunteers (n=15) were recruited in the
Department of Gastroenterology, Peking Union Medical
College Hospital and were diagnosed according to the Rome
II criteria. Biopsy samples were taken when the patients were
symptomatic. Generally, patients were in their flare of
symptoms, and colonoscopy was performed shortly after
consultation.
To evaluate the symptoms, each participant completed
a validated bowel disease questionnaire (including ques-
tions that corresponded to Rome II criteria), self-rating
depression scale, and self-rating anxiety scale. The
symptoms surveyed were abdominal distention, mucous
stool, difficult defecation, defecation urgency, incomplete
defecation, and difficulty sleeping. We have grouped
patients by symptoms at the time of the questionnaire
into IBS-D group and IBS-C group.
Table 1 Association between c-fos in CNS and clinical parameters of IBS model
c-fos in frontal lobe c-fos in hippocampus c-fos in cornu dorsale
Body weight gain R −0.763 −0.958 −0.929
P value 0.017 0.000 0.000
Colonic motility R 0.831 0.656 0.725
P value 0.005 0.055 0.027
Visceral sensation (0 ml) R 0.823 0.776 0.706
P value 0,006 0.014 0.034
Visceral sensation (0.4 ml) R 0.916 0.848 0.788
P value 0.001 0.004 0.012
Visceral sensation (0.8 ml) R 0.755 0.856 0.823
P value 0.019 0.003 0.006
Visceral sensation (1.2 ml) R 0.857 0.716 0.723
P value 0.003 0.030 0.028
Association between c-fos in CNS (frontal lobe, hippocampus, and cornu dorsale) and clinical parameters (general state, colonic motility, visceral
sensation) was analyzed using Pearson’s correlation test in IBS model rats(n=30). c-fos in CNS significantly correlated with the clinical
parameters (P<0.05)
r Pearson correlation coefficient
Int J Colorectal Dis (2011) 26:1035–1044 1037Patients enrolled in this study had no known intestinal
infectious episode that could have triggered their IBS. HCs
were recruited in outpatient department. Exclusion criteria
included GI or hepatobiliary diseases, major abdominal
surgery, allergic diseases, and other organic or severe
psychiatric disorders as assessed by history taking, appropri-
ateconsultations,andlaboratorytests.Theuse ofnonsteroidal
anti-inflammatory drugs, corticosteroids, and antimicrobial or
immunosuppressive agents was not allowed.
All participants underwent colonoscopy after cleansing
of the colon with magnesium sulfate performed in the
evening before and the morning of the procedure. Three
mucosal biopsy samples, taken from the rectosigmoid
colon, were used for TH and c-fos assays. Briefly, three
colonic biopsy samples of each study participant were
rapidly immersed in diethyl pyrocarbonate normal saline
and then transferred to Ependorf tubes in liquid nitrogen.
The specimens were stored at −80°C until use.
Analysis of TH gene expression by real-time RT-PCR
Quantitative real-time reverse transcription polymerase
chain reaction (RT-PCR) assay was used to determine the
messenger ribonucleic acid (mRNA) expression of TH in a
fluorescent temperature cycler (TransGen Technology)
following the manufacturer’s recommendations. The colon
was washed with PBS and then lysed in 1 ml Trizol
reagent, and the RNA was extracted. Total RNA was
incubated with random primers at 70°C for 5 min, 37°C
for 60 min, and 70°C for 15 min in RT reaction buffer to
make complementary deoxyribonucleic acid. PCRs were
carried out in 96-well optical reaction plates. The 30 μl
amplification mixture contained 6 μl RT reaction products
plus MgCl2 at 5 mmol/l, each primer at 0.4 μmol/l, and 2 μl
SYBR Green I mix (ABI Molecular Biochemicals). After
initial denaturation at 95°C for 15 min, reactions were
cycled 40 times as follows: denaturation at 95°C for 15 s,
annealing at 60°C for 60 s, and extension at 95°C for 15 s.
The amount of PCR products formed in each cycle was
evaluated on the basis of SYBR Green fluorescence. At the
end of each run, melting curve profiles were produced
(cooling the sample to 60°C and heating slowly to 95°C,
with continuous measurement of fluorescence) to confirm
amplification of specific transcripts. Cycle-to-cycle fluores-
cence emission readings were monitored and quantified using
the second derivative maximum method of the software
package. This method determined the crossing points of
individual samples by an algorithm that identified the first
turning point of the fluorescence curve. This turning point
corresponded to the first maximum of the second derivative
curve and correlated inversely with the log of the initial
template concentration. TH mRNA levels were normalized
with respect to β-actin level in each sample.
Primer sequences
Primer sequences for TH PCR amplification were:
forward primer (5′-ATGTTGGCTGACCGCACATT-3′)
and reverse primer (5′-CCGAATTCCACAGTGAAC
CAGT-3′); the PCR product obtained was 108 bp long.
β-actin ribosomal RNA was used as internal reference.
Primer sequences were: forward primer 5′-CATTGCT
GACAGGATGCAGAAG-3′ and reverse primer 5′-
GAGCCACCAATCCACACAGAGT-3′;t h eP C Rp r o d u c t
obtained was 107 bp long.
Data and statistical analysis
All data are expressed as means ± SE. Demographic and
personal characteristics were summarized as mean values
and standard deviations. Control group and subgroup
differences were assessed with Student’s t-tests. The
Pearson’s correlation test was used to analyze correlations
between the c-fos activity in CNS (frontal lobe, hippocam-
pus, and cornu dorsale) and the clinical parameters such as
general state, colonic motility, and colonic sensation. All
statistical analyses were executed using SPSS version 17.0
(SPSS, Chicago, IL, USA). Results that show statistical
significance (P<0.05) are reported. A P value of <0.05 was
considered statistically significant.
Results
c-fos highly expressed in CNS of IBS animal model
We analyzed expression of c-fos in CNS (frontal lobe,
hippocampus, and cornu dorsale). c-fos in CNS of IBS
animal model were significantly increased compared with
control samples(P=0.001, P=0.002, and P=0.002, respec-
tively). The c-fos in colon of IBS model was lightly higher
than that of control; however, the difference did not reach
significance (P=0.207; Fig. 2).
The correlation between expression of c-fos in CNS
and clinical parameters of IBS animal model
Compared with control animals, colonic motility (fecal
pellets) and visceral sensation (numbers of abdominal
muscle contraction induced by CRD) were significantly
higher in IBS rats, while the general state (reduction of
body weight gain) decreased significantly (P<0.05). The
results were consistent with the prior study [21]. In IBS
model rats, the clinical parameters (general state, colonic
motility, and visceral sensation) correlated with the c-fos in
CNS (frontal lobe, hippocampus, and cornu dorsale)
significantly (P<0.05; Table 1).
1038 Int J Colorectal Dis (2011) 26:1035–1044HE staining showed the pathologic histology of colon in
animal model of IBS and control rats. It could be seen that
the every layer tissue including the crypt, epithelium, and
so on is complete, without histopathologic abnormalities in
both groups (Fig. 1). However, compared with control rats,
the enterochromaffin (EC) cell and serotonin (5-HT) in the
colon of IBS model rats increased significantly (P<0.05).
Furthermore, as far as IBS model rats were concerned, c-fos
in CNS showed a significant correlation with EC cell and 5-
HT in colon (Figs. 2, 3 and 4, Tables 2 and 3).
The possible mechanism of altered noradrenergic system
in IBS
The anxiety and depression scores of IBS patients
were significantly higher than those of controls
Clinical characteristics, such as age and sex ratio, were
similar between IBS patients and controls (P>0.05).
However, IBS patients had significantly higher anxiety
and depression scores than controls (P<0.01; Table 4).
Fig. 1 No histopathological ab-
normalities could be seen in
both animal model of IBS and
controls. a The HE staining of
colon of control rat (×400). b
The HE staining of colon of IBS
model rat (×400)
Fig. 2 The expression of c-fos
in frontal lobe, hippocampus,
and cornu dorsale of IBS model
(n=30) were significantly higher
compared with controls (n=28;
P<0.05); but c-fos in colon of
IBS model and control were
similar (P>0.05). Middle line
indicates medians, and the up
and lower lines indicate inter-
quartile (5th and 95th percen-
tiles). a c-fos in frontal lobe of
IBS model and control. b c-fos
in hippocampus of IBS model
and control. c c-fos in cornu
dorsale of IBS model and con-
trol. d c-fos in colon of IBS
model and control
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four times as much as that of controls
The expression of TH mRNA in human colonic mucosa
from IBS patients was slightly higher than that from HCs
(P>0.05). Furthermore, similar tendency could be seen
between patients with IBS-D and IBS-C. Though there was
no significant difference, the expression of TH mRNA of
IBS-D patients was almost four times as much as that of
HCs (P>0.05; Table 5).
TH gene expression decreased in IBS patients
with depressive disorder
Compared with IBS patients with lower standard devia-
tion score (SDS), the TH gene expression decreased
significantly in IBS patients with higher SDS (P<0.05).
But no significant difference of TH gene could be seen
between IBS patients with higher and lower SAS (P>0.05;
Table 6).
Discussion
The previous studies about significance of NE system in
IBS focused on altered NE level in body fluid (plasma,
urine, and saliva) [15–18]. At the same time, most studies
whose investigative objects were tissues of IBS patients
were done with attention to serotonin (5-HT) system in the
colon of IBS patients [25, 26]. Until now, the significance
of NE system in colon and the c-fos expression in CNS in
IBS have not been reported. Therefore, our study firstly
Fig. 3 The c-fos staining in the
frontal lobe of IBS model and
control. The c-fos staining can
be seen both in cytoplasm and
nucleus. The yellow-brown c-
fos positive neurons distribute
irregularly in frontal lobe. The
verge of cell is distinct. The
morphology of cyton can be
spindle-shaped, oval, or irregu-
lar. a c-fos in frontal lobe of IBS
model (×400). b c-fos in frontal
lobe of control (×400)
Fig. 4 The yellow-brown 5-HT
staining can be seen in cyto-
plasm of rat’s colonic cell. a 5-
HT in colon of IBS mo (×400).
b 5-HT in colon of control
(×400)
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brain–gut interaction animal model of IBS, which was
proven well repeatable in the previous study [21], to
investigate the activity of CNS and colon of IBS (assessed
by expression of c-fos) and found that the animal model of
IBS was associated with increased c-fos in CNS but normal
c-fos in colon. Second, we found the elevated c-fos in CNS
was associated with colonic motility and sensation of
animal model of IBS. In addition, correlation analysis was
used to investigate the relationship between increased c-fos
in CNS and serotonin in colon of IBS model. Thirdly, we
used the colonic tissue obtained from IBS patients and HCs
to compare the NE signaling in the two groups. Further-
more, we tested the idea whether the NE signaling may
play a role in the different manifestation of IBS-D and IBS-
C patients.
The therapeutic option of IBS, as a functional disease,
need not involve an operation, so it is difficult to get tissue
of CNS from patients with IBS. But recent human neuro-
imaging studies have emphasized the importance of altered
CNS activity in the manifestation of IBS. So it is of great
significance to get the tissue of CNS from animal model of
IBS and to study the altered CNS activity. Our previous
study established the brain–gut interaction animal model of
IBS, and it could integrate major characteristics of IBS-D
such as altered colonic motility, visceral hypersensitivity,
and psychiatric disorder [21]. But the mechanism was
unclear. We try to answer the question in the present study.
c-fos, a marker of activation of tissue cell, is a good
object which can represent the activity of tissue. The
present study showed that the animal model of IBS was
associated with increased c-fos in CNS (frontal lobe,
hippocampus, and cornu dorsale) but normal c-fos in colon,
which showed that psychological stress might induce
hyperexcitability of colon indirectly through activation of
CNS. These data are consistent with the findings of the
study of Macsharry et al. [27], which demonstrated an
augmented colorectal distension-induced elevated c-fos in
prefrontal cortex activity in Wistar rats similar to that seen
in IBS patients. Taken together, c-fos expression in CNS is
critical for induction of visceral hypersensitivity of IBS. In
a word, the present study represented the first demonstra-
tion of significant molecular alterations specific to the CNS
in IBS animal model and supported the assumption that
psychological stress, such as the chronic and acute stress,
might induce visceral hypersensitivity mainly via activation
of CNS. That is, heightened CNS activity plays a very
important role in pathophysiologic mechanism of IBS.
These results provide a rational basis for current pharma-
cologic approaches involving regulation of CNS function in
IBS patients.
Our data showed altered colonic motility and sensa-
tion were associated with the elevated c-fos in CNS seen
in animal model of IBS. These data suggested that CNS
may interact with colon and contribute to the altered
colonic motility and sensation in IBS. And the strength
of the frontal lobe to the phenotype maybe most. Thus
Table 2 The 5-HT and EC cells in the colon of rats
5-HT in colon EC cell in colon
IBS model rats(n=30) 10.11±3.59* 22.367±22.37*
Control rats(n=28) 3.41±1.07 12.17±2.52
Compared with control rats, the serotonin(5-HT) and EC cell in the
colon of IBS model rats increased significantly (P<0.05). Values are
shown as mean ± SD
Table 3 Association between c-fos in CNS and serotonin in colon of IBS model rats
c-fos in frontal lobe c-fos in hippocampus c-fos in cornu dorsale
EC cell in colon R 0.923 0.758 0.731
P value 0.000 0.018 0.025
5-HT in colon R 0.760 0.848 0.857
P value 0.017 0.004 0.003
In IBS model rats (n=30), association between c-fos in CNS (frontal lobe, hippocampus, and cornu dorsale) and serotonin system (EC cells, 5-
HT) was analyzed using Pearson’s correlation test. The results indicate that c-fos in CNS significantly correlates with serotonin system
r Pearson correlation coefficient
Table 4 Clinical characteristics of IBS patients and controls
IBS Controls
Male:female 14:15 7:8
Age 41.5±13.6 40.8±6.7
SAS 43.1±8.9* 27.0±3.7
SDS 49.6±10.0* 27.4±2.7
No difference could be seen between IBS patients and controls in age
and sex ratio, but SAS and SDS of IBS patients were significantly
higher (P<0.01). Values are shown as mean ± SD
SAS Self-rating anxiety scale, SDS self-rating depression scale
Int J Colorectal Dis (2011) 26:1035–1044 1041pharmacogenomic studies focusing on the regulation of
expression of c-fos would be of significant interest and
potential clinical relevance in the treatment of IBS.
Correlation analysis was used to investigate the
relationship between the expression of c-fos in CNS
and serotonin in the colon of model group. The results
showed that the abnormal number of EC cells and 5-HT
level were correlated with the increased c-fos in CNS,
which supported the hypothesis that the activation of
CNS may induce activation of EC cells in the colon and
then the release of 5-HT. There is ample evidence for
elevated level of 5-HT in the colon of IBS patients [28–
31]. EC cells are likely sources. This is also supported by
the higher number of EC cells in IBS colonic tissue
compared with controls and their correlation with 5-HT
seen in the present study.
There is evidence for complex alterations in mediators
released from the colonic mucosa [7, 8, 32–35]. Our prior
study also found altered noradrenergic system in colon of
IBS model [21]. In the present study, we focused on
noradrenergic signaling (TH) in colon of IBS patients for
the first time, which is thought to play a major role in IBS
pathophysiology. Although likely, it remains speculative
how altered noradrenergic signaling contributes to dys-
functions in IBS patients such as alterations in colonic
motility, sensation, or secretion. Intriguingly, the current
results did not find difference in synthesis of NE (TH
mRNA) between IBS patients and HC. How can we
explain it? The specific NE reuptake transporter (NET) is
required to terminate the action of NE and is very
important for controlling the neural signal intensity. The
role of α2A-adrenoreceptor (AR) is presynaptic inhibition,
so downregulation of NET and α2A-AR protein will result
in increased release of NE. Our prior study found that
NET and α2A-AR in colon of IBS model decreased
significantly compared with controls [21]. So we speculate
that, instead of resulting from abnormality of TH, the
altered NE system in IBS is probably the result of other
molecular mechanism as follows: (1) the increased c-fos in
CNS, (2) the downregulation of NET and α2A-AR protein
in colon, or (3) though there was no significant difference,
the expression of TH mRNA of IBS-D patients was almost
four times as much as that of HCs. Thus the negative
result about TH in our study was probably because of the
minor sample size.
The present study shows, for the first time, that altered
noradrenergic signaling in colonic mucosa might be a
relevant factor in the pathophysiology of IBS, but the
synthesis of NE may not be the key. Although IBS-D and
IBS-C patients have distinct pathophysiologic properties,
these data showed that the expression of TH in IBS-D and
IBS-C patients was similar. Therefore, the data suggested
that some shared defects in noradrenergic signaling might
underlie the altered motility, secretion, and sensation in
IBS-D and IBS-C patients.
Recent studies confirm that impairment of the norad-
renergic system is believed to participate in the patho-
genesis of depressive disorders [36–38]. The present
study found a decrease in TH gene expression in colon
of IBS patients with higher SDS scale. We speculated that
the decrease in TH will result in hypofunction of
noradrenergic system and the hypofunction will further
induce depression-related symptoms. Taken together, the
present study showed that the IBS patients with depression
demonstrated specific change in gene expression of TH,
which indicates that drugs strengthening noradrenergic
function maybe useful in the treatment of IBS patients
with depressive disorder.
Table 5 The mRNA level of TH in human colonic mucosa
IBS-D patients (n=19) IBS-C patients (n=10) Controls (n=15)
TH mRNA 0.10876±0.35896 0.03470±0.05444 0.02768±0.04521
The expression of TH mRNA of IBS-D patients was almost four times as much as that of HCs. Values are shown as mean ± SD
Table 6 TH gene expression in IBS patients with different mood disorder
IBS patients TH mRNA IBS patients TH mRNA
SDS>50 (n=12) 0.01603±0.0095 SAS>50 (n=10) 0.02173±0.01328
SDS<50 (n=17) 0.1235±0.103 SAS<50 (n=19) 0.1001±0.0839
P 0.042 P 0.366
Compared with IBS patients with lower SDS, the TH gene expression decreased significantly in IBS patients with higher SDS. But no significant
difference of TH gene could be seen between IBS patients with higher and lower SAS
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